A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes (clinicaltrials.gov) - Sep 30, 2026 - P2 | N=367 | Completed | Sponsor: Eli Lilly and Company | Active, not recruiting ➔ Completed
Trial completion • Diabetes • Genetic Disorders • Metabolic Disorders • Obesity • Type 2 Diabetes Mellitus
|